Overview
Pancreatic beta cell agenesis with neonatal diabetes mellitus is a very rare condition present from birth in which the pancreas fails to develop the special cells — called beta cells — that normally make insulin. Insulin is a hormone the body needs to control blood sugar levels. Without working beta cells, the body cannot produce insulin at all, leading to extremely high blood sugar (glucose) levels from the first days or weeks of life. This condition is sometimes referred to as neonatal diabetes due to beta cell agenesis or congenital beta cell aplasia. Babies born with this condition typically show signs of diabetes very early — often within the first few weeks of life. Symptoms include high blood sugar, weight loss, dehydration, and failure to grow and gain weight normally. Because the pancreas also plays a role in digestion, some children may have problems absorbing nutrients from food. Treatment focuses on replacing insulin through injections or an insulin pump, which is lifesaving. Unlike the more common type 1 diabetes, this condition is caused by a genetic problem that prevents beta cells from forming in the first place, rather than an immune system attack. With careful management, children can survive and grow, but they require lifelong insulin therapy and close medical monitoring. This condition is listed as 'obsolete' in some medical databases, meaning it may now be classified under more specific genetic diagnoses.
Key symptoms:
Very high blood sugar levels from birth or early infancyFailure to gain weight or grow normally (failure to thrive)DehydrationExcessive urinationExcessive thirst or poor feedingLethargy or unusual sleepinessRapid breathingDigestive problems due to poor pancreatic functionLow birth weight in some cases
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for OBSOLETE: Pancreatic beta cell agenesis with neonatal diabetes mellitus.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for OBSOLETE: Pancreatic beta cell agenesis with neonatal diabetes mellitus at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for OBSOLETE: Pancreatic beta cell agenesis with neonatal diabetes mellitus.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Financial Resources
1 resourcesIressa
AstraZeneca Pharmaceuticals LP
Iressa Patient Support (AZ&Me)
Travel Grants
No travel grants are currently matched to OBSOLETE: Pancreatic beta cell agenesis with neonatal diabetes mellitus.
Community
No community posts yet. Be the first to share your experience with OBSOLETE: Pancreatic beta cell agenesis with neonatal diabetes mellitus.
Start the conversation →Latest news about OBSOLETE: Pancreatic beta cell agenesis with neonatal diabetes mellitus
No recent news articles for OBSOLETE: Pancreatic beta cell agenesis with neonatal diabetes mellitus.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.Which specific gene mutation is causing my child's condition, and what does that mean for their long-term health?,Should my child use an insulin pump or continuous glucose monitor, and how do we get access to these devices?,Does my child's pancreas also have trouble making digestive enzymes, and do they need enzyme supplements?,What are the signs of diabetic ketoacidosis, and exactly what should I do if I think my child is having one?,Are there any clinical trials or research studies my child might be eligible for?,What should the school nurse and teachers know about managing my child's condition safely at school?,Should other family members be tested for the gene mutation that caused this condition?
Common questions about OBSOLETE: Pancreatic beta cell agenesis with neonatal diabetes mellitus
What is OBSOLETE: Pancreatic beta cell agenesis with neonatal diabetes mellitus?
Pancreatic beta cell agenesis with neonatal diabetes mellitus is a very rare condition present from birth in which the pancreas fails to develop the special cells — called beta cells — that normally make insulin. Insulin is a hormone the body needs to control blood sugar levels. Without working beta cells, the body cannot produce insulin at all, leading to extremely high blood sugar (glucose) levels from the first days or weeks of life. This condition is sometimes referred to as neonatal diabetes due to beta cell agenesis or congenital beta cell aplasia. Babies born with this condition typica
How is OBSOLETE: Pancreatic beta cell agenesis with neonatal diabetes mellitus inherited?
OBSOLETE: Pancreatic beta cell agenesis with neonatal diabetes mellitus follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does OBSOLETE: Pancreatic beta cell agenesis with neonatal diabetes mellitus typically begin?
Typical onset of OBSOLETE: Pancreatic beta cell agenesis with neonatal diabetes mellitus is neonatal. Age of onset can vary across affected individuals.
What treatment and support options exist for OBSOLETE: Pancreatic beta cell agenesis with neonatal diabetes mellitus?
1 patient support program are currently tracked on UniteRare for OBSOLETE: Pancreatic beta cell agenesis with neonatal diabetes mellitus. See the treatments and support programs sections for copay assistance, eligibility, and contact details.